Diagnostic Performances of Computed TomographIc Coronary Angiography and Intravascular Ultrasound (IMAGES-FFR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01400230|
Recruitment Status : Completed
First Posted : July 22, 2011
Last Update Posted : March 24, 2015
|Condition or disease||Intervention/treatment|
|Diagnosis Coronary Artery Disease||Procedure: diagnostic procedures CCTA, CAG, IVUS and FFR|
Correlation between CCTA, IVUS and FFR will be evaluated. The presence of myocardial ischemia will be assessed by fractional flow reserve (FFR).
Diagnostic performance (sensitivity, specificity, positive predictive/negative predictive values and diagnostic accuracy) of each modality will be assessed and compared.
|Study Type :||Observational|
|Actual Enrollment :||150 participants|
|Official Title:||Diagnostic Performances of the Computed Tomographic Coronary Angiography and IntraVascular UltraSound to Evaluate Ischemia Causing Coronary Artery Stenosis|
|Study Start Date :||March 2008|
|Actual Primary Completion Date :||December 2011|
|Actual Study Completion Date :||December 2011|
Patients suspected ischemic heart disease by the symptom and CCTA and undergone IVUS and FFR in the Cath Lab with CAG enrolled consecutively.
Procedure: diagnostic procedures CCTA, CAG, IVUS and FFR
Diagnostic procedures including computed tomography, coronary angiography, intravascular ultrasound, fractional flow reserve were performed in the patients suspected ischemic heart disease.
- Diagnostic accuracy [ Time Frame: 1 day ]
Evaluate and compare the diagnostic accuracy of the CCTA, IVUS and angiographic parameters for the prediction of myocardial ischemia (FFR<0.8)
- CCTA: % area stenosis
- IVUS: minimum lumen area
- Angiography: % diameter stenosis
Diagnostic accuracy of each parameter: (true positive+true negative)/total cases
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01400230
|Korea, Republic of|
|Inje University Ilsan Paik Hospital|
|Goyang, Gyeonggi-do, Korea, Republic of, 411-706|
|Study Director:||Joon Hyung Doh, MD, PhD||Inje University|
|Principal Investigator:||Bon-Kwon Koo, MD, PhD||Seoul National University Hospital|